Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-1-21
pubmed:abstractText
Ceramide, a mediator of proinflammatory cytokine signaling, induces cartilage degradation and reduces type II collagen synthesis in articular cartilage. The accumulation of ceramide is associated with arthritis in Farber's disease. The aim of this study was to investigate the mechanism of ceramide-induced down-regulation of type II collagen.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type II, http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, http://linkedlifedata.com/resource/pubmed/chemical/High Mobility Group Proteins, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-fos, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-raf, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/SOX9 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/Sphingomyelin Phosphodiesterase, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
209-20
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18163502-Animals, pubmed-meshheading:18163502-Cartilage, Articular, pubmed-meshheading:18163502-Cattle, pubmed-meshheading:18163502-Cells, Cultured, pubmed-meshheading:18163502-Chondrocytes, pubmed-meshheading:18163502-Collagen Type II, pubmed-meshheading:18163502-Culture Media, pubmed-meshheading:18163502-Down-Regulation, pubmed-meshheading:18163502-Genes, Immediate-Early, pubmed-meshheading:18163502-High Mobility Group Proteins, pubmed-meshheading:18163502-MAP Kinase Kinase 1, pubmed-meshheading:18163502-MAP Kinase Kinase 2, pubmed-meshheading:18163502-MAP Kinase Signaling System, pubmed-meshheading:18163502-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:18163502-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:18163502-Proto-Oncogene Proteins c-fos, pubmed-meshheading:18163502-Proto-Oncogene Proteins c-raf, pubmed-meshheading:18163502-RNA, Messenger, pubmed-meshheading:18163502-SOX9 Transcription Factor, pubmed-meshheading:18163502-Sphingomyelin Phosphodiesterase, pubmed-meshheading:18163502-Transcription Factors
pubmed:year
2008
pubmed:articleTitle
Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway.
pubmed:affiliation
Cardiff University, Cardiff, Wales, UK. GilbertSJ1@Cardiff.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't